Phototransformation of hematoporphyrin in aqueous solution: Anomalous behavior at low oxygen concentration

The photoactivation of a photosensitizer is the initial step in photodynamic therapy (PDT) where photochemical reactions result in the production of reactive oxygen species and eventually cell death. In addition to oxidizing biomolecules, some of these photochemical reactions lead to photosensitizer degradation at a rate dependent on the oxygen concentration among other factors. We investigated photodegradation of Photogem ® (28 μM), a hematoporphyrin derivative, at different oxygen concentrations (9.4 to 625.0 μM) in aqueous solution. The degradation was monitored by fluorescence spectroscopy. The degradation rate (M/s) increases as the oxygen concentration increases when the molar ratio of oxygen to Photogem® is greater than 1. At lower oxygen concentrations (<25 μM) an inversion of this behavior was observed. The data do not fit a simple kinetic model of first-order dependence on oxygen concentration. This inversion of the degradation rate at low oxygen concentration has not previously been demonstrated and highlights the relationship between photosensitizer and oxygen concentrations in determining the photobleaching mechanism(s). The findings demonstrate that current models for photobleaching are insufficient to explain completely the effects at low oxygen concentration.

[1]  A F Mironov,et al.  Hematoporphyrin derivatives: an oligomeric composition study. , 1990, Journal of photochemistry and photobiology. B, Biology.

[2]  J. R. Perussi,et al.  Correlation of cytotoxicity and depth of necrosis of the photoproducts of photogem® , 2007 .

[3]  W. Dietel,et al.  Phototransformation of Sensitisers: 3. Implications for Clinical Dosimetry , 1998, Lasers in Medical Science.

[4]  V. Bagnato,et al.  PDT experience in Brazil: A regional profile. , 2005, Photodiagnosis and photodynamic therapy.

[5]  V. Bagnato,et al.  Comparative study of photodegradation of three hematoporphyrin derivative: Photofrin®, Photogem®, and Photosan® , 2007 .

[6]  R. Rotomskis,et al.  Phototransformations of porphyrins in aqueous and micellar media. , 1993, Journal of photochemistry and photobiology. B, Biology.

[7]  C. Sibata,et al.  Aggregation susceptibility on phototransformation of hematoporphyrin derivatives , 2008 .

[8]  J. Moan,et al.  Singlet oxygen in photosensitization. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[9]  J. R. Perussi,et al.  Photodynamic therapy for Photogem® and Photofrin® using different light wavelengths in 375 human melanoma cells , 2007 .

[10]  R. Kołos,et al.  Optimal oxygen concentration for the detection of single indocarbocyanine molecules in a polymeric matrix , 2005 .

[11]  C. Sibata,et al.  Photosensitizers in clinical PDT. , 2004, Photodiagnosis and photodynamic therapy.

[12]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[13]  Michael S. Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells¶ , 2005 .

[14]  R. Bonnett,et al.  Photobleaching of sensitisers used in photodynamic therapy , 2001 .

[15]  Michael S Patterson,et al.  In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. , 2003, Cancer research.

[16]  M S Patterson,et al.  Modeling of photosensitizer fluorescence emission and photobleaching for photodynamic therapy dosimetry. , 1998, Applied optics.

[17]  A. Treston,et al.  Nickel(II)-promoted ethanolysis and hydrolysis of N-(2-pyridylmethyl)urea. A model for urease , 1982 .

[18]  Jarod C Finlay,et al.  Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. , 2004, Physics in medicine and biology.

[19]  Brian C Wilson,et al.  Photodynamic therapy for cancer: principles. , 2002, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[20]  L. Bezdetnaya,et al.  Spectroscopic and Biological Testing of Photobleaching of Porphyrins in Solutions * , 1996, Photochemistry and photobiology.

[21]  J. Moan,et al.  A spectroscopic study of the photobleaching of protoporphyrin IX in solution , 2003, Lasers in Medical Science.

[22]  M. Orrit,et al.  Photoblinking of Rhodamine 6G in Poly(vinyl alcohol): Radical Dark State Formed through the Triplet , 2003 .

[23]  V. Bagnato,et al.  Correlation between the photostability and photodynamic efficacy for different photosensitizers , 2006 .

[24]  T. Foster,et al.  Singlet Oxygen‐Versus Nonsinglet Oxygen‐Mediated Mechanisms of Sensitizer Photobleaching and Their Effects on Photodynamic Dosimetry , 1998, Photochemistry and photobiology.

[25]  W. Potter,et al.  PHOTOBLEACHING OF PHOTOFRIN II AS A MEANS OF ELIMINATING SKIN PHOTOSENSITIVITY * , 1987, Photochemistry and photobiology.

[26]  M G Nichols,et al.  The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.

[27]  A. Douplik,et al.  Oxygen consumption and photobleaching in whole blood incubated with photosensitizer induced by laser irradiation , 2003 .

[28]  J Moan,et al.  Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.

[29]  Claudio H. Sibata,et al.  Experimental determination of threshold dose in photodynamic therapy in normal rat liver , 2007 .